Study of cutaneous manifestations in patients with polycystic ovarian syndrome attending a tertiary care centre
<p class="abstract"><strong>Background:</strong> Polycystic ovary syndrome (PCOS) is a multisystem metabolic disorder, which has a significant impact on the quality of life as well as fertility.<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372429/#ref1"><sup>1</sup></a><sup>,</sup><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372429/#ref2"><sup>2</sup></a> Acne, hirsutism, androgenetic alopecia, acanthosis nigricans, seborrhea are commonly associated with cutaneous manifestations of PCOS. To identify cutaneous manifestations, their incidence and frequency in patients with PCOS in different age groups.</p><p class="abstract"><strong>Methods:</strong> An institutional based prospective study. <em>Seventy PCOS patients attending out-patient departments of DVL and Obstetrics and Gynaecology, NRI Medical College and General Hospital, Guntur, </em>fulfilling the inclusion criteria were included in the study and examined for the presence of cutaneous manifestations in the two year study period between January 2017 and December 2018.<strong></strong></p><p class="abstract"><strong>Results:</strong> In the present study, 70 patients with PCOS were taken up and the commonest age group affected was 21-25 years (42.8%). Positive family history of PCOS was observed in 12.8%. The commonest cutaneous manifestation was acne vulgaris (57.14 %). Obesity was present in 47.14% of the patients and all of them were found to have striae. Hirsutism was observed in 47.14% of the total patients studied and the majority of them had terminal hair in the chin region and upper lip. Acanthosis nigricans was present in 34.28%, seborrhoea in 21.42% and acrochordons in 17.14% of the patients. Of the 70 patients, 15.7% were overweight and 47.14% were obesity.</p><p class="abstract"><strong>Conclusions:</strong> The cutaneous manifestations of PCOS reserves major role in its management by Dermatologist. Recognizing PCOS in women presenting with hyperandrogenism offers a significant opportunity to begin a life-long conversation about prevention and treatment of a condition that has a multi-system impact on affected women.</p>